American International Group
AIG
$80.74
+2.05%
American International Group (AIG) is a global insurance and financial services conglomerate operating through subsidiaries that underwrite property, casualty, and life insurance across commercial and personal lines, with the General Insurance segment generating the overwhelming majority of group revenue. AIG is a legacy market leader in commercial P&C insurance, distinguished by its global underwriting footprint, multinational client base, and a multi-year restructuring that has simplified the group into a focused general insurance underwriter following the Corebridge life spin-off, in which it retains a minority stake. The current investor narrative centers on whether AIG's underwriting margin recovery and expense discipline can offset soft commercial pricing and elevated catastrophe losses, with the stock's persistent underperformance versus the broader market and a recent post-earnings rally keeping the debate between value-oriented buyers and skeptics focused on reserve adequacy and capital return. Management's aggressive buyback program and a modest dividend are central to the bull case, while the bear case points to tepid top-line growth, a low return on equity relative to peers, and the overhang of a still-unwound Corebridge stake.…
AIG
American International Group
$80.74
Investment Opinion: Should I buy AIG Today?
The synthesized recommendation is a Hold with a positive bias, reflecting a balanced risk/reward. The core thesis is that AIG offers a deep value opportunity with a 9.16x forward PE and a 1.18x price-to-book, supported by a fortress balance sheet and a 2.02% dividend yield, but stagnant revenue growth and margin compression limit near-term upside. The analyst consensus rating of 'buy' with an average target price of $87.70 (implying +8.6% upside) anchors the view that downside is limited.
Supporting evidence includes the forward PE of 9.16x versus the sector's 10x-13x range, a 10%-30% discount; revenue growth of 0.62% YoY, which is tepid but stable; a net margin of 13.38% that, while compressed, remains respectable; free cash flow of $3.85 billion supporting buybacks and dividends; and the implied upside to the average analyst target. The low beta of 0.528 adds defensive appeal.
Key risks that could invalidate the thesis include a continued decline in underwriting margins, adverse reserve development, and a failure to return capital effectively. The rating would upgrade to Buy if the forward PE remains below 10x and revenue growth accelerates above 2%, or if the company demonstrates sustained margin expansion. It would downgrade to Sell if revenue growth turns negative or if the net margin falls below 10%. Relative to its history and peers, AIG appears undervalued, but the discount is partly justified by its low ROE and growth prospects.
Sign up to view all
AIG 12-Month Price Forecast
AIG presents a balanced risk/reward with a neutral stance. The stock is cheap on forward earnings and book value, supported by a strong balance sheet and capital return program, but weak revenue growth and margin pressure limit upside. The analyst consensus is moderately bullish, but the tight target range suggests limited near-term catalysts. I would upgrade to bullish if the company demonstrates sustained margin expansion and revenue growth acceleration, and downgrade to bearish if earnings disappoint or reserve issues emerge.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on American International Group's 12-month outlook, with a consensus price target around $87.70 and implied upside of +8.6% versus the current price.
Average Target
$87.70
0 analysts
Implied Upside
+8.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$80 - $101
Analyst target range
Coverage is robust with 20 analysts, and the consensus recommendation is "buy" with a recommendation mean of 2.32 (where lower is more bullish), indicating a moderately bullish but not euphoric stance. The average target price is $87.70, which implies roughly +8.6% upside from the current $80.74, and notably even the lowest target of $80.00 sits essentially at the current price, meaning the Street sees virtually no downside from here. The consensus leans constructive but tempered, consistent with a value stock where the debate is about the pace of margin recovery rather than existential risk.
The target range spans $80.00 to $101.00, a spread of about 26% of the current price that signals moderate rather than high conviction. The high target of $101.00 (roughly +25.1% upside) likely assumes multiple expansion toward 10.5x-11x forward EPS of $9.54 plus successful reserve stabilization and continued buybacks, while the low target of $80.00 essentially prices in flat earnings and no re-rating. Institutional ratings show a stable-to-cautious pattern: recent actions include Mizuho Neutral (September 16), Argus Buy (September 2), Cantor Fitzgerald Overweight (August 17), Morgan Stanley Equal Weight (August 12), KBW Outperform (August 11), and RBC, Wells Fargo, Piper Sandler, and Barclays all at neutral/equal-weight in August, with no upgrades or downgrades in the action column. The absence of rating changes suggests analysts are in a wait-and-see mode, and the tight clustering of neutral ratings alongside a buy consensus mean points to a stock with limited near-term catalysts but a favorable risk/reward skew.
Bulls vs Bears: AIG Investment Factors
The bull and bear cases are finely balanced, but the bear side currently has slightly stronger evidence given the stagnant revenue growth (0.62% YoY), margin compression (net margin down from 16.25% to 13.38%), and persistent relative underperformance (-10.70% vs. S&P 500 over one year). However, the bull case is supported by a deep valuation discount (9.16x forward PE vs. peers at 10x-13x), a fortress balance sheet (debt-to-equity of 0.223), and a consensus analyst target of $87.70 implying +8.6% upside. The single most important tension is whether AIG can stabilize underwriting margins and return to profitable growth, or whether soft commercial pricing and catastrophe losses will keep ROE depressed and the stock range-bound. Resolution of this debate will likely determine whether the stock breaks above $87.29 resistance or tests the $71.25 support.
Bullish
- Deep discount to peers on forward earnings: AIG trades at a forward PE of 9.16x on consensus EPS of $9.54, versus a typical diversified insurance peer range of 10x-13x. The 1.18x price-to-book is also at the low end of the 1.2x-1.6x peer band, implying roughly 10%-30% valuation discount that is partly unjustified given the improving margin trajectory.
- Strong balance sheet and robust cash generation: Debt-to-equity is just 0.223 and trailing free cash flow is $3.85 billion, with Q2 2026 FCF of $1.716 billion. This financial flexibility supports the aggressive buyback ($645 million in Q2 2026, $508 million in Q1 2026) and the 2.02% dividend yield with a conservative 31.5% payout ratio.
- Analyst consensus sees limited downside: The average target price of $87.70 implies +8.6% upside, and even the lowest target of $80.00 is essentially at the current price. With 20 analysts covering and a 'buy' consensus (mean 2.32), the Street is constructive on the margin recovery story.
- Recent momentum turning positive: The stock has rebounded 8.9% from its September 25 low of $74.17 to $80.74, with a 1-month relative strength of +4.92% versus the S&P 500. This acceleration after a flat three-month stretch could signal an early trend reversal, especially with the stock still 7.5% below its 52-week high.
Bearish
- Stagnant revenue growth: Q2 2026 revenue grew just 0.62% year over year to $7.085 billion, with no acceleration in the multi-quarter trend. The entire growth story rests on commercial P&C pricing and volume, which are facing soft market conditions, capping multiple expansion potential.
- Margin compression versus prior year: Q2 2026 net margin fell to 13.38% from 16.25% a year earlier, and EBITDA margin declined to 32.51% from 35.89%. This compression suggests catastrophe losses or softer underwriting are biting, and the trailing net margin of 11.56% remains below historical levels.
- Low return on equity: ROE is only 7.53% and ROA is 1.77%, well below the 10%-12% ROE typical of best-in-class P&C underwriters. This low profitability justifies the valuation discount and raises questions about the quality of earnings, which are largely driven by investment income and reserve releases rather than superior underwriting.
- Persistent relative underperformance: AIG has lagged the S&P 500 by 10.70% over the past year and by 16.12% year-to-date, with a 1-year price change of just +4.83% versus SPY's +15.53%. The 52-week maximum drawdown of -16.98% underscores that rallies in this name have historically been sold.
AIG Technical Analysis
AIG is in a range-bound consolidation phase rather than a sustained trend, with a 1-year price change of just +4.83% that badly lags the S&P 500's +15.53% (relative strength of -10.70% over twelve months). At the current price of $80.74, the stock sits at roughly 59.2% of its 52-week range of $71.25 to $87.29, meaning it is in the upper-middle of the band but still about 7.5% below its high. This positioning suggests neither momentum overextension nor a falling-knife setup, but rather a stock that has repeatedly failed to break out while finding buyers on dips. The year-to-date change of -4.19% versus SPY's +11.93% (relative strength of -16.12% YTD) confirms that AIG has been a persistent relative laggard despite the recent bounce.
Short-term momentum has turned decisively positive and is diverging from the weak longer-term trend: the 1-month change is +6.14% versus SPY's +1.22%, producing a relative strength of +4.92% over the past month, while the 3-month change is a flat +0.30% and the 6-month change is +2.62%. The most recent session added +2.05% on volume of roughly 5.41 million shares, and the stock has climbed from $74.17 on September 25 to $80.74 on October 16, a roughly 8.9% rebound off the late-September trough. This acceleration after a flat three-month stretch looks like a mean-reversion rally or early trend reversal rather than a temporary blip, though the 1-year underperformance argues for confirmation before extrapolating. The 52-week maximum drawdown of -16.98% underscores that rallies in this name have historically been sold.
Key technical levels are well defined: support sits at the 52-week low of $71.25, with secondary support near the September low around $72.78, while resistance is the 52-week high of $87.29, roughly 8.1% above the current $80.74. A breakout above $87.29 would signal a genuine trend change and likely require fundamental confirmation from underwriting margins or capital return, whereas a breakdown below $71.25 would mark a fresh 52-week low and validate the bear case. The stock's beta of 0.528 means it is roughly 47% less volatile than the market, which supports larger position sizing for a given risk budget but also implies AIG will likely lag in strong risk-on rallies, consistent with its 1-year relative strength of -10.70%.
Beta
0.53
0.53x market volatility
Max Drawdown
-17.0%
Largest decline past year
52-Week Range
$71-$87
Price range past year
Annual Return
+4.8%
Cumulative gain past year
| Period | AIG Return | S&P 500 |
|---|---|---|
| 1m | +6.1% | +0.2% |
| 3m | +0.3% | +2.9% |
| 6m | +2.6% | +8.4% |
| 1y | +4.8% | +14.9% |
| ytd | -4.2% | +11.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AIG Fundamental Analysis
Revenue growth is essentially stagnant: Q2 2026 revenue of $7.085 billion grew just 0.62% year over year versus $7.041 billion in Q2 2025, and the multi-quarter trend shows sequential revenue of $6.650 billion in Q1 2026, $6.557 billion in Q4 2025, and $6.402 billion in Q3 2025, implying a low-single-digit annualized run rate with no acceleration. The General Insurance segment dominates at $6.72 billion of the reported $7.085 billion total, while Corporate Nonsegment and Reconciling Items contribute $123 million and -$92 million respectively, so the entire growth story rests on commercial P&C pricing and volume. With revenue up only 0.62% YoY against a consensus forward revenue estimate of roughly $32.89 billion, the investment case is clearly not growth-driven but rather margin- and capital-return-driven, which caps multiple expansion potential.
Profitability is solid but uneven: Q2 2026 net income was $948 million on a 13.38% net margin, with gross margin of 36.71% and operating margin of 19.25%, while the trailing net margin is 11.56% and gross margin 34.51%. Margins have compressed from the prior year, when Q2 2025 net income was $1.144 billion on a 16.25% net margin and 38.36% gross margin, and Q2 2026 EBITDA of $2.303 billion (32.51% margin) compares with $2.527 billion (35.89%) a year earlier. The quarterly progression shows net margin of 11.47% in Q1 2026, 11.21% in Q4 2025, and 8.11% in Q3 2025, indicating a modest recovery off the 2025 trough but still below prior-year levels. For a diversified insurer, a 13% net margin and 19% operating margin are respectable but not exceptional, and the compression versus Q2 2025 suggests catastrophe losses or softer underwriting are biting.
Balance sheet and cash flow metrics are the strongest part of the story: debt-to-equity is just 0.223, the current ratio is 0.853 (typical for insurers with large investment portfolios), and trailing free cash flow is $3.85 billion, with Q2 2026 FCF of $1.716 billion and Q1 2026 FCF of only $155 million due to working-capital swings. ROE is a modest 7.53% and ROA just 1.77%, well below what a 1.18x price-to-book would ideally command, while the payout ratio of 31.5% and dividend yield of 2.02% leave ample room for the buyback, which totaled $645 million in Q2 2026 and $508 million in Q1 2026. The company clearly funds growth and returns internally, but the low ROE and thin net margin mean the FCF is largely a function of investment income and reserve releases rather than superior underwriting economics.
Quarterly Revenue
$7.1B
2026-06
Revenue YoY Growth
+0.6%
YoY Comparison
Gross Margin
36.7%
Latest Quarter
Free Cash Flow
$3.9B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AIG Overvalued?
Because AIG is profitable (Q2 2026 net income of $948 million), the PE ratio is the primary metric: the trailing PE is 15.61x while the forward PE is just 9.16x, an unusually wide gap that implies the market expects earnings to roughly double, consistent with consensus EPS of $9.54 versus the trailing figure implied by the $0.064 reported EPS anomaly in the key metrics (which appears to be a data artifact). The forward PE of 9.16x on estimated EPS of $9.54 against a $80.74 price is the more reliable anchor, and it signals the market is pricing AIG as a low-growth, capital-return value stock rather than a compounder. The PEG ratio of -0.04 is not meaningful given the distorted trailing EPS base.
On peer comparison, AIG trades at a price-to-book of 1.18x, a price-to-sales of 1.81x, and an EV/EBITDA of 7.28x, with a trailing PE of 15.61x versus a forward PE of 9.16x. Diversified insurance peers typically trade in the 10x-13x forward PE range and 1.2x-1.6x book, so AIG's 9.16x forward PE represents a discount of roughly 10%-30% to the sector, while its 1.18x book is at the low end of the peer band. That discount is arguably justified by the 7.53% ROE, which trails the 10%-12% ROE typical of best-in-class P&C underwriters, and by revenue growth of just 0.62%, though it also suggests limited downside if margins stabilize.
Historically, AIG's own PE band has been extremely wide, ranging from 10.4x in Q2 2026 and 13.2x in Q1 2026 to 15.7x in Q4 2025 and 20.9x in Q3 2025, with a price-to-book that has drifted from 1.20x in Q2 2025 down to 0.98x in Q2 2026. The current 1.18x book and 15.6x trailing PE sit in the middle-to-lower portion of the two-year range, suggesting the market is not pricing in optimistic expectations and that valuation is closer to a value opportunity than a momentum trap, provided earnings estimates of $9.54 are met. The 2.02% dividend yield and 31.5% payout ratio further support a floor valuation argument.
PE
15.6x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 3x~25x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
7.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are moderate but centered on earnings quality and growth. Revenue growth is essentially flat at 0.62% YoY, and net margin has compressed to 13.38% from 16.25% a year earlier, while ROE is a modest 7.53%—well below peers. The company's earnings rely heavily on investment income and reserve releases rather than superior underwriting, and any adverse reserve development could significantly impact profitability. Additionally, the current ratio of 0.853 is typical for insurers but leaves little room for liquidity shocks.
Market and competitive risks include valuation compression if the stock fails to meet earnings expectations. AIG trades at a forward PE of 9.16x, which is already a discount to peers, but if margin recovery stalls, the multiple could contract further toward the 52-week low valuation. The beta of 0.528 means the stock is less sensitive to market swings, but it also implies it will lag in strong rallies, as evidenced by the 1-year relative strength of -10.70%. Competitive pressures in commercial P&C insurance, including soft pricing and new entrants, could limit premium growth. Regulatory risks and catastrophe losses are ever-present for insurers, and AIG's global footprint exposes it to geopolitical and regulatory headwinds.
The worst-case scenario would involve a combination of a major catastrophe loss, adverse reserve development from legacy liabilities, and a failed attempt to unwind the Corebridge stake, leading to a sharp earnings miss and multiple compression. In such a scenario, the stock could retest its 52-week low of $71.25, representing a decline of approximately 11.8% from the current price of $80.74. A more severe outcome, such as a ratings downgrade or a significant capital raise, could push the stock below the 52-week low toward the $65-$70 range, implying a downside of 13%-19%. The maximum drawdown over the past year was -16.98%, which serves as a reasonable estimate of the potential loss in a adverse scenario.
FAQ
The key risks include: 1) Financial risk: margin compression (net margin down to 13.38% from 16.25%) and low ROE (7.53%) could persist, limiting earnings growth. 2) Competitive risk: soft commercial P&C pricing and intense competition could constrain revenue growth, which is already just 0.62% YoY. 3) Macro risk: as a global insurer, AIG is exposed to catastrophe losses and geopolitical events, which can cause earnings volatility. 4) Company-specific risk: the overhang of the Corebridge stake and potential adverse reserve development from legacy liabilities. The most severe risk is a combination of these factors leading to a retest of the 52-week low of $71.25, an 11.8% decline.
Our 12-month forecast has three scenarios: Bull (25% probability) target $95-$101, Base (55%) target $85-$90, and Bear (20%) target $71-$80. The base case is most likely, assuming AIG meets consensus EPS of $9.54 and continues its buyback program, driving the stock toward the analyst average target of $87.70. The bull case requires margin expansion and multiple re-rating, while the bear case assumes earnings miss and reserve issues. The key assumption for the base case is stable underwriting margins and no major catastrophes.
AIG appears undervalued relative to its peers and its own history. The forward PE of 9.16x is below the 10x-13x range for diversified insurers, and the price-to-book of 1.18x is at the low end of the peer band. The trailing PE of 15.61x is elevated due to a depressed earnings base, but the forward multiple suggests the market is pricing in a low-growth, capital-return story. The PEG ratio is not meaningful due to negative earnings growth. The valuation implies the market expects modest earnings growth and no major re-rating, which could prove conservative if margins recover.
AIG can be a good buy for value-oriented investors with a medium-to-long-term horizon, given its discounted valuation (9.16x forward PE) and strong balance sheet. The analyst consensus target of $87.70 implies +8.6% upside, and the low target of $80.00 suggests limited downside. However, the stock faces headwinds from stagnant revenue growth (0.62% YoY) and margin compression, so it may not appeal to growth investors. The biggest downside risk is a retest of the 52-week low of $71.25, representing an 11.8% decline. Overall, it is a moderate buy for those seeking value and income, but not a high-growth opportunity.
AIG is more suitable for long-term investment (minimum 2-3 years) given its low beta (0.528), stable dividend (2.02% yield), and value characteristics. Short-term trading is less attractive due to the stock's range-bound behavior and lack of near-term catalysts. The low volatility and defensive nature make it a good holding for conservative portfolios, but the stagnant growth means it may not deliver high returns. A holding period of at least 2 years allows time for margin recovery and capital return to materialize.